To continue getting breaking news and the full stories from The Boston Globe, subscribe today.

The Boston Globe

Business

Boston.com

Gottesdiener is Rhythm’s CEO

By Chris Reidy

 |  Globe Staff  

  November 09, 2011

Rhythm, a Boston biotechnology company, announced today the appointment of Keith M. Gottesdiener, M.D., as chief executive. Gottesdiener joins Rhythm from Merck & Co., Inc., where he served as vice president and late-stage therapeutic group leader, with responsibility for trials of Merck’s products. Rhythm is focused on developing peptide therapeutics that address metabolic diseases.

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

Free access for home delivery subscribers.

Just need to link your home delivery account; one easy step.

Link my home delivery account

BostonGlobe.comSubscriber Log In

Contact us for help